Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Johnson

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Brain Research. Molecular Brain Research|August 23, 2002
Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's diseaseBoris S Spektor, David W Miller, Zane R Hollingsworth, et al.
Biochemistry|January 21, 2011
Requirements for Skp1 processing by cytosolic prolyl 4(trans)-hydroxylase and α-N-acetylglucosaminyltransferase enzymes involved in O₂ signaling in dictyosteliumHanke van der Wel, Jennifer M Johnson, Yuechi Xu, et al.
Glycobiology|May 27, 2009
Molecular analysis of a UDP-GlcNAc:polypeptide alpha-N-acetylglucosaminyltransferase implicated in the initiation of mucin-type O-glycosylation in Trypanosoma cruziNorton Heise, Divyendu Singh, Hanke van der Wel, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabAnnie E Moroco, Kathryn Nunes, Angela Alnemri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2010
Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancerJean J Latimer, Jennifer M Johnson, Crystal M Kelly, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
Cell Reports. Medicine|April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomesYuting Shan, Yingbo Huang, Adam Lee, et al.
Frontiers in Cell and Developmental Biology|April 20, 2017
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast CancerJennifer M Johnson, Paolo Cotzia, Roberto Fratamico, et al.
Cancer Medicine|August 18, 2021
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trialsRenata Ferrarotto, Ian Anderson, Balazs Medgyasszay, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Brain Research. Molecular Brain Research|August 23, 2002
Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's diseaseBoris S Spektor, David W Miller, Zane R Hollingsworth, et al.
Biochemistry|January 21, 2011
Requirements for Skp1 processing by cytosolic prolyl 4(trans)-hydroxylase and α-N-acetylglucosaminyltransferase enzymes involved in O₂ signaling in dictyosteliumHanke van der Wel, Jennifer M Johnson, Yuechi Xu, et al.
Glycobiology|May 27, 2009
Molecular analysis of a UDP-GlcNAc:polypeptide alpha-N-acetylglucosaminyltransferase implicated in the initiation of mucin-type O-glycosylation in Trypanosoma cruziNorton Heise, Divyendu Singh, Hanke van der Wel, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabAnnie E Moroco, Kathryn Nunes, Angela Alnemri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2010
Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancerJean J Latimer, Jennifer M Johnson, Crystal M Kelly, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
Cell Reports. Medicine|April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomesYuting Shan, Yingbo Huang, Adam Lee, et al.
Frontiers in Cell and Developmental Biology|April 20, 2017
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast CancerJennifer M Johnson, Paolo Cotzia, Roberto Fratamico, et al.
Cancer Medicine|August 18, 2021
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trialsRenata Ferrarotto, Ian Anderson, Balazs Medgyasszay, et al.
Pageof 9